Search Results - "Jing, Zhouhong"
-
1
Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer
Published in Breast cancer research : BCR (12-04-2024)“…This study aimed to explore potential indicators associated with the neoadjuvant efficacy of TCbHP regimen (taxane, carboplatin, trastuzumab, and pertuzumab)…”
Get full text
Journal Article -
2
miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer
Published in OncoTargets and therapy (01-07-2019)“…Previous research had shown that an imbalance in cell proliferation and apoptosis is a vital mechanism for tumorigenesis and cancer progression that may…”
Get full text
Journal Article -
3
Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
Published in Breast cancer targets and therapy (01-01-2023)“…Metaplastic breast cancer (MBC) is an extremely rare malignant breast disease that has rarely been reported. The molecular subtype of MBC is mostly…”
Get full text
Journal Article -
4
The use of 5-fluorouracil-loaded nanobubbles combined with low-frequency ultrasound to treat hepatocellular carcinoma in nude mice
Published in European journal of medical research (21-11-2017)“…This study aimed to investigate the therapeutic effects of 5-fluorouracil (5-FU)-loaded nanobubbles irradiated with low-intensity, low-frequency ultrasound in…”
Get full text
Journal Article -
5
Quantification of Hepatic Steatosis on Dual-Energy CT in Comparison With MRI mDIXON-Quant Sequence in Breast Cancer
Published in Journal of computer assisted tomography (01-01-2024)“…The study aimed to evaluate the correlation and diagnostic value of liver fat quantification in unenhanced dual-energy CT (DECT) using quantitative magnetic…”
Get full text
Journal Article -
6
Abstract PO3-14-05: Integration of metabolomics and transcriptomics to Reveal Potential Biomarkers Associated with Treatment Response of Neoadjuvant Therapy in HER2+ Breast Cancer
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Abstract Background: Neoadjuvant therapy (NAT) has become the standard treatment for early human epidermal growth factor receptor 2 positive (HER2+) breast…”
Get full text
Journal Article -
7
Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
Published in Breast cancer (Dove Medical Press) (01-01-2023)“…BackgroundMetaplastic breast cancer (MBC) is an extremely rare malignant breast disease that has rarely been reported. The molecular subtype of MBC is mostly…”
Get full text
Report